Answers are grounded in this paper and cite their sources.
Despite its pleiotropic nature, GSK-3 has significant promise as a target for diabetes due to functional partitioning of the enzyme, tissue-selectivity and acute dosage-dependency of effects of inhibition, suggesting useful therapeutic windows.
No takes yet. Share an insight, caveat, or question.
MacAulay et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: